Disrupted Cav1.2 Selectivity Causes Overlapping Long QT and Brugada Syndrome Phenotypes in CACNA1C-E1115K iPS Cell Model

1.

Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S.

Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium

channel. Nature Jul 20 1989;340:230-233.

2.

Yang J, Ellinor PT, Sather WA, Zhang JF, Tsien RW. Molecular determinants of Ca2+

selectivity and ion permeation in L-type Ca2+ channels. Nature Nov 11 1993;366:158-161.

3.

Heinemann SH, Terlau H, Stühmer W, Imoto K, Numa S. Calcium channel characteristics

conferred on the sodium channel by single mutations. Nature Apr 2 1992;356:441-443.

4.

Burashnikov E, Pfeiffer R, Barajas-Martinez H, et al. Mutations in the cardiac L-type calcium

channel associated with inherited J-wave syndromes and sudden cardiac death. Heart rhythm

Dec 2010;7:1872-1882.

5.

Ye D, Tester DJ, Zhou W, Papagiannis J, Ackerman MJ. A pore-localizing CACNA1CE1115K missense mutation, identified in a patient with idiopathic QT prolongation,

bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid

nonselective monovalent cation channel. Heart rhythm Feb 2019;16:270-278.

6.

Yamamoto Y, Makiyama T, Harita T, et al. Allele-specific ablation rescues

electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a

CALM2 mutation. Human molecular genetics May 1 2017;26:1670-1677.

7.

Yoshinaga D, Baba S, Makiyama T, et al. Phenotype-Based High-Throughput Classification

of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells. Stem Cell

Reports Aug 13 2019;13:394-404.

8.

Horvath B, Banyasz T, Jian Z, Hegyi B, Kistamas K, Nanasi PP, Izu LT, Chen-Izu Y.

Dynamics of the late Na(+) current during cardiac action potential and its contribution to

afterdepolarizations. J Mol Cell Cardiol Nov 2013;64:59-68.

9.

Himeno Y, Asakura K, Cha CY, Memida H, Powell T, Amano A, Noma A. A human

ventricular myocyte model with a refined representation of excitation-contraction coupling.

Biophys J Jul 21 2015;109:415-427.

10.

Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantù F, Towbin JA, Keating MT,

Hammoude H, Brown AM, Chen LS, Colatsky TJ. Long QT syndrome patients with

mutations of the SCN5A and HERG genes have differential responses to Na+ channel

blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation

Dec 15 1995;92:3381-3386.

11.

Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the

long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel

blockers on transmural dispersion of repolarization and torsade de pointes. Circulation Nov

24 1998;98:2314-2322.

12.

Bos JM, Crotti L, Rohatgi RK, Castelletti S, Dagradi F, Schwartz PJ, Ackerman MJ.

Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2

Long QT Syndrome. Circ Arrhythm Electrophysiol May 2019;12:e007280.

13.

Gao Y, Xue X, Hu D, Liu W, Yuan Y, Sun H, Li L, Timothy KW, Zhang L, Li C, Yan GX.

Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in

timothy syndrome. Circ Arrhythm Electrophysiol Jun 2013;6:614-622.

14.

Badri M, Patel A, Patel C, Liu G, Goldstein M, Robinson VM, Xue X, Yang L, Kowey PR,

Yan GX. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired

Long QT Syndrome Refractory to Conventional Measures. JACC Clin Electrophysiol Aug

2015;1:315-322.

15.

Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A is associated with

mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest Jun 2008;118:22192229.

16.

Bezzina C, Veldkamp MW, van Den Berg MP, Postma AV, Rook MB, Viersma JW, van

Langen IM, Tan-Sindhunata G, Bink-Boelkens MT, van Der Hout AH, Mannens MM, Wilde

AA. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ

Res Dec 3-17 1999;85:1206-1213.

17.

Shryock JC, Song Y, Rajamani S, Antzelevitch C, Belardinelli L. The arrhythmogenic

consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res Sep 1

2013;99:600-611.

18.

Wu L, Ma J, Li H, Wang C, Grandi E, Zhang P, Luo A, Bers DM, Shryock JC, Belardinelli

L. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on

ventricular repolarization. Circulation Apr 26 2011;123:1713-1720.

19.

Guo D, Lian J, Liu T, Cox R, Margulies KB, Kowey PR, Yan GX. Contribution of late

sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse usedependence of QT-prolonging agents. Heart rhythm May 2011;8:762-769.

20.

Maltsev VA, Undrovinas AI. A multi-modal composition of the late Na+ current in human

ventricular cardiomyocytes. Cardiovasc Res Jan 2006;69:116-127.

21.

Viatchenko-Karpinski S, Kornyeyev D, El-Bizri N, Budas G, Fan P, Jiang Z, Yang J,

Anderson ME, Shryock JC, Chang CP, Belardinelli L, Yao L. Intracellular Na+ overload

causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes.

J Mol Cell Cardiol Nov 2014;76:247-256.

22.

Xi J, Khalil M, Shishechian N, et al. Comparison of contractile behavior of native murine

ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem

cells. Faseb j Aug 2010;24:2739-2751.

23.

Hess P, Lansman JB, Tsien RW. Calcium channel selectivity for divalent and monovalent

cations. Voltage and concentration dependence of single channel current in ventricular heart

cells. The Journal of general physiology Sep 1986;88:293-319.

...